Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonin receptor subtypes and affective disorders

D S Robinson1

  • 1Central Nervous System Clinical Research, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 06492-7660.

Clinical Neuropharmacology
|January 1, 1993
PubMed
Summary

Drugs targeting serotonin (5-hydroxytryptamine or 5-HT) receptors are crucial for understanding and treating affective disorders. New research highlights advances in these serotonergic medications for anxiety and depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.

Rhinology·2017
Same author

Inhaled allergen challenge in assessment of biologics for asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.

Allergy·2013
Same author

Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety.

Rhinology·2013
Same author

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy.

Allergy·2011
Same author

Activin-A: a novel critical regulator of allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Affective disorders, including anxiety and depression, are complex conditions with significant unmet treatment needs.
  • Serotonin (5-hydroxytryptamine or 5-HT) is a key neurotransmitter implicated in mood regulation.
  • Dysregulation of the serotonin system is associated with the pathophysiology of mood disorders.

Purpose of the Study:

  • To discuss the role of drugs acting on serotonin receptor subtypes in the etiology and treatment of affective disorders.
  • To describe the mechanisms of action of drugs affecting serotonin.
  • To highlight recent therapeutic advances in serotonergic drugs.

Main Methods:

  • Review of existing literature on serotonergic drugs and affective disorders.

Related Experiment Videos

  • Analysis of mechanisms of action for anxiolytic and antidepressant drugs targeting serotonin.
  • Synthesis of evidence supporting serotonin's role in mood disorders.

    • Main Results:

    • Drugs acting on 5-HT receptor subtypes play a significant role in affective disorders.
    • Specific mechanisms of action for anxiolytic and antidepressant serotonergic drugs are detailed.
    • Evidence supports serotonin's involvement in the development and treatment of mood disturbances.

    Conclusions:

    • Serotonergic agents are vital in managing affective disorders.
    • A new generation of serotonergic drugs represents therapeutic progress.
    • Further research into serotonin pathways may yield novel treatments for mood disorders.